analytics_image
\
Vantage Market Research
Vantage Market Research

Reports - Contraceptive Drugs Market

iconHealthcare

Contraceptive Drugs Market

Contraceptive Drugs Market Size, Share & Trends Analysis Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives) by Age Group (15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years) by End User (Homecare, Hospitals, Clinics) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Historic Data (2021 - 2023) & Forecast Period (2025 - 2035)

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insights

Market Size in 2024

USD 19.80 Billion

Market Size By 2035

USD 49.75 Billion

CAGR (2025 - 2035)

8.75%

Largest Region

North America

Fastest Region

Asia Pacific

Base Year

2024

Historic Data

2021 - 2023

Forecast Period

2025 - 2035

Segments Covered

By Product, By Age Group, By End User, By Region

Report Coverage

The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.

Overview

Global Contraceptive Drugs Market:

Contraceptive Drugs Market - By Product, Age Group, End User, and Region.

Contraceptive Drugs Market Size, 2024 To 2035 (USD Billion)

Market Synopsis:

The global Contraceptive Drugs Market is valued at USD 19.80 Billion in 2024 and is projected to reach a value of USD 49.75 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 8.75% between 2025 and 2035.

Contraception is a method used to prevent unwanted pregnancies and reduce the risk of sexually transmitted infections aka STIs. Rising awareness for birth control and safe sex practices are expected to bolster the demand for Contraceptive Drugs across the world in the coming years. The increasing availability of sex education and rising focus on safe sex practices to avoid unwanted pregnancies are expected to aid Contraceptive Drugs Market growth over the coming years. Increased use of contraception in young women is expected to crucially shape Contraceptive Drugs Market potential across the forecast period.

The increasing availability of convenient and modern contraceptives and the high availability of preferred contraceptives are also expected to bolster the Contraceptive Drugs Market growth through 2028. However, health risks associated with prolonged use of Contraceptive Drugs are anticipated to have a constraining effect on the overall Contraceptive Drugs Market growth. The lockdown of 2020 led to a downfall of the Contraceptive Drugs Market as multiple sales channels were closed. However, the Contraceptive Drugs Market is expected to make a rapid recovery in the post-pandemic era as the world has now returned to normal and restrictions have been lifted.

Market Segmentation:

The Global Contraceptive Drugs Market is segmented based on Product, Age Group, and End-User. Based on the End-User the market is segmented as Homecare, Hospitals, and Clinics. Based on Product, the market is segmented as Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives. Based on Age Group, the market is segmented as 15–24 years, 25–34 years, 35–44 years, and Above 44 years.

Based on End-user:

Based on End-user, the market is segmented as Homecare, Hospitals, and Clinics. The Home Care segment accounts for a prominent market share. Increasing consumption of oral contraceptives to prevent STIs and unwanted pregnancies is expected to drive demand in this segment across the forecast period. Increased demand for after-intercourse contraceptives is also expected to favor the growth of the home care segment in the Global Contraceptive Drugs Market landscape through 2028.

Based on Product-

Based on Product, the market is segmented into Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives. The Oral Contraceptive Pills segment is anticipated to account for a dominant market share across the forecast period owing to the high preference for such contraceptives among consumers. The reversible nature of these contraceptives drives their popularity. High convenience and effectiveness are other factors that propel growth in this segment over the coming years. Injectable Contraceptives are anticipated to witness a rise in demand at a fast Compound Annual Growth Rate (CAGR) over the forecast period.

North America Accounts for a Dominant Market Share

Based on all the regions, the North American region is expected to lead the Global Contraceptive Drugs Marketplace. The presence of developed healthcare infrastructure, adequate sex education, high availability of Contraceptive Drugs, and high consumer spending potential are major factors that influence the Contraceptive Drugs Market potential in this region. The high prevalence of STIs is also expected to boost the adoption of contraceptives in this region. The United States is anticipated to account for a significant market share in the North American market. The region held a market share of 45.1% in 2021 and was valued at USD 5.4 billion. The demand for Contraceptive Drugs is expected to rise fastest in the Asia Pacific region owing to increasing awareness for contraceptives and government initiatives to boost the same.

Competitive Landscape:

The key players in the Global Contraceptive Drugs Market include- Agile Therapeutics and others.

Segmentation of the Global Contraceptive Drugs Market:

Market Segmentation

ParameterDetails
Segment Covered

By Product

  • Oral Contraceptive Pills (89.5%)
  • Injectable Contraceptives (5.5%)
  • Topical Contraceptives (5.0%)

By Age Group

  • 15–24 Years
  • 25–34 Years
  • 35–44 Years
  • Above 44 Years

By End User

  • Homecare
  • Hospitals
  • Clinics

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific)
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa
Companies Covered
  • Agile Therapeutics
  • Allergan PLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Piramal Healthcare
  • Mylan N.V.
  • Pfizer Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
Customization ScopeEnjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data.
Pricing and purchase optionsAccess flexible purchase options tailored to your specific research requirements. Explore purchase options

Report coverage & Deliverables

Our PDF Reports And Online Dashboard
Will Help You Stay Ahead In The Market.

    Key features include:

  • Check
    Competitive benchmarking
  • Check
    Historical data and future forecasts
  • Check
    Company-wise revenue breakdown
  • Check
    Regional growth opportunities
  • Check
    Latest market trends and dynamics
  • Check
    Impact of emerging technologies like AI and automation
  • Check
    Key regulatory updates and ESG considerations

FAQ‘s

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by
Contraceptive Drugs Market Size | Industry Report, 2035